ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

PMVP vs NTHI // PIOTROSKI F-SCORE QUALITY

PMV Pharmaceuticals Inc. (NASDAQ) VS. NeOnc Technologies Holdings Inc. (NASDAQ) • 15-METRIC TALLY: PMVP 2 — NTHI 1
▲ PIOTROSKI F-SCORE QUALITY LEADER: PMVP
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PMVP VS. NTHI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC PMVP NTHI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — -21.93% — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — -51.80% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality ACTIVE 2/9 1/9 +1.00 PMVP /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 47.5 54.3 -6.80 NTHI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $98.9M $97.0M $1.9M PMVP /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR PMVP REV NTHI REV PMVP GROSS % NTHI GROSS % PMVP FCF NTHI FCF
FY 2025 $241.4M $40.0K — — -$73.6M -$20.4M
FY 2024 $239.3M $83.0K — — -$51.9M -$4.2M
FY 2023 $224.4M — — — -$55.7M —
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PMVP // BETA —
NTHI // BETA —